Search results
Results from the WOW.Com Content Network
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
Vaccinated or boosted individuals can obtain New York ... The mask requirement follows news that more than 500,000 COVID-19 vaccine ... the state recommends visiting epass.ny.gov to retrieve a new ...
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
In September 2021, the anti-vaccine group America's Frontline Doctors (AFLDS) filed a lawsuit attempting to overturn New York City's proof of vaccination mandate. The suit alleged that the mandate was inherently discriminating against African Americans , citing a perceived hesitation towards vaccines among this population stemming from the ...
The latest COVID vaccines are updated to better reflect the currently circulating strains of the SARS CoV-2 virus, says David Cennimo, M.D., infectious disease expert and associate professor of ...
The Janssen COVID‑19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, [1] is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, [24] and its Belgian parent company Janssen Pharmaceuticals, [25] a subsidiary of American company Johnson & Johnson. [26] [27] [28]
New York State lowered its vaccine age from 75 to 65 on January 11, 2021. [101] As of January 25, 2021, 628,831 vaccines had been administered in New York City. [102] During the last week of the month, the city was averaging 5,000 new cases per day and around 60 deaths per day. [103]
Novavax successfully developed a COVID-19 vaccine that is currently its only product on the market. The company has been working on two other candidates. One is an investigational influenza vaccine.